Skip Nav Destination
Issues
Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome
Vallijah Subasri; Nicholas Light; Nisha Kanwar; Jack Brzezinski; Ping Luo; Jordan R. Hansford; Elizabeth Cairney; Carol Portwine; Christine Elser; Jonathan L. Finlay; Kim E. Nichols; Noa Alon; Ledia Brunga; Jo Anson; Wendy Kohlmann; Kelvin C. de Andrade; Payal P. Khincha; Sharon A. Savage; Joshua D. Schiffman; Rosanna Weksberg; Trevor J. Pugh; Anita Villani; Adam Shlien; Anna Goldenberg; David Malkin
Ultra High-plex Spatial Proteogenomic Investigation of Giant Cell Glioblastoma Multiforme Immune Infiltrates Reveals Distinct Protein and RNA Expression Profiles
Shilah A. Bonnett; Alyssa B. Rosenbloom; Giang T. Ong; Mark Conner; Aric B.E. Rininger; Daniel Newhouse; Felicia New; Chi Q. Phan; Saskia Ilcisin; Hiromi Sato; John S. Lyssand; Gary Geiss; Joseph M. Beechem
Genome-wide CRISPR Screen Reveals RAB10 as a Synthetic Lethal Gene in Colorectal and Pancreatic Cancers Carrying SMAD4 Loss
Hélène Erasimus; Vanessa Kolnik; Frédéric Lacroix; Sukhvinder Sidhu; Stéphane D'Agostino; Olivier Lemaitre; Alexandre Rohaut; Isabelle Sanchez; Gilbert Thill; Michel Didier; Laurent Debussche; Christophe Marcireau
Integrative Metatranscriptomic Analysis Reveals Disease-specific Microbiome–host Interactions in Oral Squamous Cell Carcinoma
Vinay Jain; Divyashri Baraniya; Doaa E. El-Hadedy; Tsute Chen; Michael Slifker; Fadhl Alakwaa; Kathy Q. Cai; Kumaraswamy N. Chitrala; Christopher Fundakowski; Nezar N. Al-Hebshi
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
Payal D. Shah; Alexander C. Huang; Xiaowei Xu; Robert Orlowski; Ravi K. Amaravadi; Lynn M. Schuchter; Paul Zhang; Julia Tchou; Tina Matlawski; Amanda Cervini; Joanne Shea; Joan Gilmore; Lester Lledo; Karen Dengel; Amy Marshall; E. John Wherry; Gerald P. Linette; Andrea Brennan; Vanessa Gonzalez; Irina Kulikovskaya; Simon F. Lacey; Gabriela Plesa; Carl H. June; Robert H. Vonderheide; Tara C. Mitchell
Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas
Anne-Sophie Sertier; Anthony Ferrari; Roxane M. Pommier; Isabelle Treilleux; Sandrine Boyault; Mojgan Devouassoux-Shisheboran; Janice Kielbassa; Emilie Thomas; Laurie Tonon; Vincent Le Texier; Amandine Charreton; Anne-Pierre Morel; Anne Floquet; Florence Joly; Dominique Berton-Rigaud; Gwenaël Ferron; Laurent Arnould; Sabrina Croce; Guillaume Bataillon; Pierre Saintigny; Eliane Mery-Lamarche; Christine Sagan; Aruni P. Senaratne; Ivo G. Gut; Fabien Calvo; Alain Viari; Maria Ouzounova; Isabelle Ray-Coquard; Alain Puisieux
Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans
Wonkyung Oh; Alyssa Min Jung Kim; Deepika Dhawan; Perry M. Kirkham; Raluca Ostafe; Jackeline Franco; Uma K. Aryal; Robert H. Carnahan; Valery Patsekin; J. Paul Robinson; Deborah W. Knapp; Seung-Oe Lim
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy
Vasu R. Sah; Henrik Jespersen; Joakim Karlsson; Lisa M. Nilsson; Mattias Bergqvist; Iva Johansson; Ana Carneiro; Hildur Helgadottir; Max Levin; Gustav Ullenhag; Anders Ståhlberg; Roger Olofsson Bagge; Jonas A. Nilsson; Lars Ny
EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
Ritu Chaudhary; Robbert J.C. Slebos; Leenil C. Noel; Feifei Song; Maria I. Poole; Dirk S. Hoening; Juan C. Hernandez-Prera; Jose R. Conejo-Garcia; Jose A. Guevara-Patino; Xuefeng Wang; Mengyu Xie; Aik Choon Tan; Christine H. Chung
Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells
S.M. Rafiqul Islam; Takuya Maeda; Naritaka Tamaoki; Meghan L. Good; Rigel J. Kishton; Biman C. Paria; Zhiya Yu; Marta Bosch-Marce; Nicole M. Bedanova; Chengyu Liu; Michael J. Kruhlak; Nicholas P. Restifo; Raul Vizcardo
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells
Diana Saleiro; Ewa M. Kosciuczuk; Mariafausta Fischietti; Ricardo E. Perez; G. Sohae Yang; Frank Eckerdt; Elspeth M. Beauchamp; Ye Hou; Qixuan Wang; Rona Singer Weinberg; Eleanor N. Fish; Feng Yue; Ronald Hoffman; Leonidas C. Platanias
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds